Antag Therapeutics is a biopharmaceutical company developing treatments for obesity and cardiometabolic diseases, focusing on injectable therapies like their novel GIPR antagonist, AT-7687.

Adcendo is a biotech company focused on developing antibody-drug conjugates for treating cancers with high unmet needs.

Bambusa Therapeutics Inc. develops bispecific antibodies for treating immunological and inflammatory disorders.

Agomab Therapeutics is a Belgian biotech company developing novel treatments for fibrosis, with a pipeline of growth factor targeting antibodies and small molecule compounds.